Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

NGM Biopharmaceuticals, Inc.

Clinical trials sponsored by NGM Biopharmaceuticals, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug aims to stop cancer wasting in colorectal patients Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1

Cancer combo trial pulled before it even started

Disease control Cancelled

This was a phase 2 study planned to test a new drug called NGM707 combined with the immunotherapy pembrolizumab in people with advanced or metastatic solid tumors, specifically colorectal cancer. The goal was to see if the combination could shrink tumors and to check for side eff…

Phase 2 • Sponsor: NGM Biopharmaceuticals, Inc • Aim: Disease control

Last updated Jun 27, 2026 12:04 UTC